Post-kala-azar dermal leishmaniasis
Post-kala-azar dermal leishmaniasis (PKDL) is a condition that occurs in some individuals who have been treated for visceral leishmaniasis (VL), also known as kala-azar. It is characterized by a skin rash that appears after the treatment of the visceral form of the disease.
Epidemiology[edit]
PKDL is most commonly seen in regions where visceral leishmaniasis is endemic, such as parts of India, Sudan, and Bangladesh. The incidence of PKDL varies by region, with higher rates reported in Sudan compared to the Indian subcontinent.
Pathophysiology[edit]
The exact mechanism of PKDL is not fully understood. It is believed to be related to the immune response to the Leishmania parasites that cause visceral leishmaniasis. The condition manifests as a result of the body's attempt to clear residual parasites from the skin.
Clinical Features[edit]
PKDL typically presents with a variety of skin lesions, which can include:
- Hypopigmented macules
- Erythematous papules
- Nodules
These lesions usually appear on the face, arms, and upper trunk. The condition can be disfiguring and may persist for several months to years if not treated.
Diagnosis[edit]
Diagnosis of PKDL is primarily clinical, based on the appearance of characteristic skin lesions in a patient with a history of visceral leishmaniasis. Laboratory confirmation can be achieved through:
- Skin biopsy
- Polymerase chain reaction (PCR) tests
- Serological tests
Treatment[edit]
Treatment of PKDL involves the use of anti-leishmanial drugs. Commonly used medications include:
The choice of treatment may vary based on the region and the availability of drugs.
Prognosis[edit]
The prognosis for PKDL is generally good with appropriate treatment. However, the condition can be chronic and may require prolonged therapy. Untreated PKDL can serve as a reservoir for the Leishmania parasites, potentially contributing to the spread of visceral leishmaniasis.
Prevention[edit]
Preventive measures for PKDL are primarily focused on controlling visceral leishmaniasis through:
- Vector control programs to reduce the population of sandflies
- Early diagnosis and treatment of visceral leishmaniasis
- Health education and awareness campaigns
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian